T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$1.66B |
| 2 |
KLA
KLAC
|
+$1.39B |
| 3 |
T-Mobile US
TMUS
|
+$1.38B |
| 4 |
Eli Lilly
LLY
|
+$1.37B |
| 5 |
CSX Corp
CSX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.2B |
| 2 |
Microsoft
MSFT
|
+$3.24B |
| 3 |
Amazon
AMZN
|
+$2.75B |
| 4 |
Netflix
NFLX
|
+$2.53B |
| 5 |
Apple
AAPL
|
+$2.48B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.66% |
| 2 | Financials | 11.78% |
| 3 | Healthcare | 11.44% |
| 4 | Consumer Discretionary | 10.75% |
| 5 | Communication Services | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
Dolby
DLB
$5.82B
| $5.02M | ﹤0.01% |
78,163
+3,366
| +5% | +$226K |
|
1377
Kite Realty
KRG
$5.31B
| $5.01M | ﹤0.01% |
208,889
+5,618
| +3% | +$128K |
|
1378
uniQure
QURE
$3.28B
| $4.99M | ﹤0.01% |
208,646
-704,534
| -77% | -$27.2M |
|
1379
James River Group Holdings
JRVR
$194M
| $4.98M | ﹤0.01% |
783,258
-263,106
| -25% | -$1.51M |
|
1380
CNX Resources
CNX
$5.3B
| $4.97M | ﹤0.01% |
135,183
+167
| +0.1% | +$5.98K |
|
1381
Wyndham Hotels & Resorts
WH
$5.46B
| $4.95M | ﹤0.01% |
65,556
+3,603
| +6% | +$272K |
|
1382
Ameris Bancorp
ABCB
$6.01B
| $4.95M | ﹤0.01% |
66,574
+1,888
| +3% | +$140K |
|
1383
ONE Gas
OGS
$5.09B
| $4.87M | ﹤0.01% |
63,077
+1,598
| +3% | +$128K |
|
1384
Chemed
CHE
$6.94B
| $4.86M | ﹤0.01% |
11,368
+463
| +4% | +$202K |
|
1385
Lear
LEA
$8.28B
| $4.85M | ﹤0.01% |
42,329
+1,113
| +3% | +$119K |
|
1386
Macy's
M
$6.19B
| $4.81M | ﹤0.01% |
218,295
+9,047
| +4% | +$185K |
|
1387
Valley National Bancorp
VLY
$8.29B
| $4.81M | ﹤0.01% |
411,846
+13,960
| +4% | +$155K |
|
1388
Southwest Gas
SWX
$6.68B
| $4.81M | ﹤0.01% |
60,051
+2,217
| +4% | +$178K |
|
1389
Liberty Broadband Class C
LBRDK
$5.27B
| $4.79M | ﹤0.01% |
98,652
-242,338
| -71% | -$12.6M |
|
|
MAZE
1390
Maze Therapeutics
MAZE
$1.51B
| $4.79M | ﹤0.01% |
115,711
+105,237
| +1,005% | +$3.62M |
|
1391
Darling Ingredients
DAR
$10.5B
| $4.79M | ﹤0.01% |
132,960
+1,258
| +1% | +$42.6K |
|
1392
Teleflex
TFX
$5.8B
| $4.78M | ﹤0.01% |
39,157
+1,623
| +4% | +$197K |
|
1393
Morningstar
MORN
$7.72B
| $4.73M | ﹤0.01% |
21,777
-45,724
| -68% | -$9.9M |
|
1394
Maximus
MMS
$2.9B
| $4.71M | ﹤0.01% |
54,567
+2,726
| +5% | +$233K |
|
1395
Carriage Services
CSV
$575M
| $4.7M | ﹤0.01% |
110,952
+7,941
| +8% | +$345K |
|
1396
SiriusPoint
SPNT
$2.73B
| $4.7M | ﹤0.01% |
214,437
+35,222
| +20% | +$706K |
|
1397
Starwood Property Trust
STWD
$6.09B
| $4.7M | ﹤0.01% |
260,666
+13,706
| +6% | +$252K |
|
1398
WEX
WEX
$6.65B
| $4.69M | ﹤0.01% |
31,482
+809
| +3% | +$122K |
|
1399
Antero Midstream
AM
$10.7B
| $4.68M | ﹤0.01% |
263,330
+16,037
| +6% | +$289K |
|
1400
Gold Royalty Corp
GROY
$732M
| $4.68M | ﹤0.01% |
+1,159,335
| New | +$4.44M |
|
Similar funds
T. Rowe Price Associates's Q4 2025 Portfolio in Review
As of Q4 2025, T. Rowe Price Associates held 3,154 positions worth $927B, down 0.78% from $935B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q4 2025 filing shows 113 new, 1,841 increased, 860 reduced and 65 closed positions. Its largest new stake was Medline Inc: 7,325,104 shares worth $308M. The largest sale was NVIDIA, an estimated $4.2B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q4 2025 buy was Medline Inc: 7,325,104 shares worth $308M.
- T. Rowe Price Associates added most to Lam Research in Q4 2025, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $4.2B.
- T. Rowe Price Associates fully exited Akero Therapeutics in Q4 2025, selling an estimated $181M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $927B portfolio in Q4 2025.
- T. Rowe Price Associates opened 113 new positions and closed 65 in Q4 2025.
- T. Rowe Price Associates's portfolio value fell 0.78% quarter-over-quarter to $927B.
Based on T. Rowe Price Associates's 13F filing for Q4 2025, filed 17 Feb 2026.